Newborn Screening Market Report
First published: 15 October 2024 | Last updated: 28 May 2026 | Report Code: newborn-screening
Newborn Screening Market — USD $4.5 Billion in 2023, Growing to USD 8.26null by 2033 at 6.1% CAGR
This report provides a comprehensive analysis of the Newborn Screening market, covering key insights and data from 2023 to 2033, including market size, growth projections, segmentation, and regional dynamics.
Key Takeaways
- Global market value grows from $4.50 Billion in 2023 to $8.26 Billion in 2033 with a 6.1% CAGR over 2023 to 2033.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- Latin America is the regional market region with an implied 6.46% CAGR, increasing from $0.23 Billion to $0.43 Billion by 2033.
- Europe and Asia Pacific show notable expansion: Europe from $1.16 Billion to $2.12 Billion, Asia Pacific from $0.98 Billion to $1.79 Billion.
- Key companies include PerkinElmer, Inc., Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Roche Diagnostics.
Newborn Screening Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. This report analyzes the Newborn Screening market across product, test type, technology, application, and regional dimensions, highlighting a rise from $4.50 Billion in 2023 to $8.26 Billion in 2033 at a 6.1% CAGR over 2023 to 2033. Growth is driven by expanded screening programs, technological improvements in molecular diagnostics and immunoassays, and broader public health initiatives. The analysis examines reagent and testing equipment demand, biochemical and genetic test adoption, and laboratory services roles. Regional breakdowns identify North America as the largest market and Latin America as the regional market region. The report profiles leading vendors — PerkinElmer, Inc., Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Roche Diagnostics — and evaluates market dynamics, regulatory influences, and implementation barriers. Findings are intended to inform strategic planning, market entry, and investment decisions within the life-sciences sector.
Key Growth Drivers
- Expansion of national and regional newborn screening programs increases testing volume and demand for reagents and equipment.
- Advances in molecular diagnostics and genetic testing enable broader panels and higher detection accuracy, supporting market uptake.
- Rising emphasis on early diagnosis and preventive child health policies fuels investment in laboratory infrastructure and services.
- Collaborations among hospitals, public agencies, and private firms accelerate adoption of standardized screening protocols and technologies.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $4.50 Billion |
| CAGR (2023-2033) | 6.1% |
| 2033 Market Size | $8.26 Billion |
| Top Companies | PerkinElmer, Inc., Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Roche Diagnostics |
| Published Date | 15 October 2024 |
| Last Modified Date | 28 May 2026 |
Newborn Screening Market Overview
Customize Newborn Screening Market Report market research report
- ✔ Get in-depth analysis of Newborn Screening market size, growth, and forecasts.
- ✔ Understand Newborn Screening's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Newborn Screening
What is the Market Size & CAGR of Newborn Screening Market Report market in 2023?
Newborn Screening Industry Analysis
Newborn Screening Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Newborn Screening Market Report Market Analysis Report by Region
Europe Newborn Screening Market Report:
Europe grows from $1.16 Billion in 2023 to $2.12 Billion in 2033. Uptake is driven by regulatory support for early diagnostic initiatives, integration of genetic testing in clinical workflows, and investments in laboratory capabilities across public and private providers.Asia Pacific Newborn Screening Market Report:
Asia Pacific grows from $0.98 Billion in 2023 to $1.79 Billion in 2033. Growth reflects expanding public health screening coverage, improving laboratory networks, and rising awareness of newborn health that promote adoption of testing technologies and services.North America Newborn Screening Market Report:
North America is largest regional market, rising from $1.53 Billion in 2023 to $2.81 Billion in 2033. Regional expansion is underpinned by established screening programs, healthcare infrastructure, and adoption of advanced diagnostic platforms, which support sustained demand for reagents, equipment, and services.South America Newborn Screening Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.23 Billion in 2023 to $0.43 Billion in 2033. 23 Billion in 2023 to $0.43 Billion in 2033, identified as the regional growth market with an implied 6.46% CAGR. Expansion is supported by gradual implementation of screening programs, capacity building in diagnostics, and growing public health initiatives.Middle East & Africa Newborn Screening Market Report:
Middle East and Africa grows from $0.6 Billion in 2023 to $1.1 Billion in 2033. Market development is influenced by strengthening healthcare systems, targeted newborn health policies, and investments to expand laboratory services and diagnostic access.Tell us your focus area and get a customized research report.
Research Methodology
Newborn Screening Market Analysis By Test Type
The Newborn Screening market, segmented by test type, includes key categories such as biochemical tests, genetic tests, and physiological tests. Biochemical tests dominate the market, accounting for $2.83 billion in 2023, with a growth forecast to $5.19 billion by 2033. Genetic tests and physiological tests are also significant, reflecting the industry's shift towards advanced testing methodologies.
Newborn Screening Market Analysis By Product
Products used in newborn screening include reagents, testing equipment, and laboratory services. Reagents account for a substantial market share, expected to grow from $2.83 billion in 2023 to $5.19 billion in 2033, while testing equipment is projected to rise from $1.09 billion to $2.00 billion during the same period.
Newborn Screening Market Analysis By Technology
The technology segment of the Newborn Screening market is advancing rapidly, influenced by molecular diagnostics, immunoassays, chromatography, and other technologies. Molecular diagnostics currently leads with a projected increase from $2.83 billion in 2023 to $5.19 billion by 2033.
Newborn Screening Market Analysis By Application
The primary applications within the Newborn Screening market encompass metabolic disorders, endocrine disorders, infectious diseases, and more. Metabolic disorders are the largest segment growing from $1.83 billion in 2023 to $3.35 billion in 2033, boosted by increased screening initiatives and awareness.
Newborn Screening Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Newborn Screening Industry
PerkinElmer, Inc.:
A global leader in newborn screening solutions, PerkinElmer provides a wide range of innovative tests and technologies to ensure the health and wellbeing of newborns.Abbott Laboratories:
Abbott is a major player in the healthcare industry, offering comprehensive newborn screening products that leverage advanced technology for effective screening.Thermo Fisher Scientific:
Thermo Fisher Scientific provides various diagnostics solutions for newborn screening, emphasizing innovation and high-quality testing.Agilent Technologies:
Agilent focuses on advanced instrumentations and technologies for genetic screening, enhancing the accuracy and efficiency of newborn health assessments.Roche Diagnostics:
Roche provides diagnostic solutions that aid in the early detection of various metabolic conditions, ensuring that newborns receive timely interventions.We're grateful to work with incredible clients.
FAQs
What is the market size of the Newborn Screening Market Report in 2023?
The market size in 2023 is $4.50 Billion according to the provided data and forms the baseline for the 2023 to 2033 forecast period.
How big will the market be in 2033?
The market is projected to reach $8.26 Billion in 2033 based on the supplied forecast figures covering 2023 to 2033.
What is CAGR of the market for 2023 to 2033?
The compound annual growth rate (CAGR) for the 2023 to 2033 forecast period is 6.1% as provided in the input data.
Which region is the fastest Growing in the Newborn Screening Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.23 Billion in 2023 to $0.43 Billion in 2033, reflecting an implied 6.46% CAGR over the forecast period.
Which region is the fastest Growing and why?
Latin America is named the regional market region, with an implied 6.46% CAGR and expansion from $0.23 Billion to $0.43 Billion during 2023 to 2033.
Who are the top companies in this market?
Top companies listed include PerkinElmer, Inc., Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, and Roche Diagnostics as provided.
What product segments are covered in the segmentation?
Segmentation includes by-product categories such as Reagents, Testing Equipment, and Laboratory Services as specified in the input data.
What test types are included in the report?
The report covers biochemical tests, genetic tests, and physiological tests as the by-test-type subsegments provided.